Search Result

Results for "

Immunogenic Peptide

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Biochemical Assay Reagents (50) CCR (1) Fluorescent Dye (1) HPV (2) Influenza Virus (1) MDM-2/p53 (1) MHC (1) NF-κB (1) Nuclear Factor of activated T Cells (NFAT) (1) PD-1/PD-L1 (1) Reactive Oxygen Species (ROS) (1) Thrombopoietin Receptor (1) Transmembrane Glycoprotein (1)
By Research Areas:	Cancer (12) Infection (3) Inflammation/Immunology (10) Neurological Disease (1)
Click Chemistry:	Azide (7) Alkynes (7)

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

Click Chemistry

Targets Recommended: Formyl Peptide Receptor (FPR) Connective Peptide Peptide-Drug Conjugates (PDCs) Natriuretic Peptide Receptor (NPR) RXFP Receptor CGRP Receptor Amyloid-β

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P3719

MOG(35-55) amide, mouse, rat 1 Publications Verification	CCR	Inflammation/Immunology
MOG peptide (35-55) is a fragment 35-55 of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide. MOG peptide (35-55) is specific to expanded CD4 ⁺ T cells, and induces experimental autoimmune encephalomyelitis (EAE) in animal model .

HY-P1610

Asudemotide	PD-1/PD-L1	Cancer
Asudemotide (S-588410) is a peptide of human DEP domain-containing protein 1A. Asudemotide is an immunostimulant. Asudemotide has a sequence of H-Glu-Tyr-Tyr-Glu-Leu-Phe-Val-Asn-Ile-OH. Asudemotide induces a tumor immune response in esophageal cancer. .

HY-P2853A

Hemocyanin-SMCC	Biochemical Assay Reagents	Others
Hemocyanin-SMCC is a hemocyanin that can be used as a carrier protein to couple low molecular weight molecules such as peptides, nucleic acids, drugs or toxins to make them highly immunogenic.

HY-174359C

Alkyne-PEG-NH2 (MW 5000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 5000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359D

Alkyne-PEG-NH2 (MW 10000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 10000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359

Alkyne-PEG-NH2 (MW 1000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 1000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359B

Alkyne-PEG-NH2 (MW 3400)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 3400) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359E

Alkyne-PEG-NH2 (MW 20000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 20000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359H

Alkyne-PEG-NH2 (MW 40000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 40000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359A

Alkyne-PEG-NH2 (MW 2000)	Biochemical Assay Reagents	Others
Alkyne-PEG-NH2 (MW 2000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-P10701

Q11 peptide	Biochemical Assay Reagents	Inflammation/Immunology Cancer
Q11 peptide is a β-sheet-forming peptide that plays an important role in self-assembly and targeted applications. As a scaffold peptide, Q11 peptide can display immunogenic epitopes and is widely used in peptide-based immune vaccine research. Additionally, Q11 peptide can be conjugated with MUC1 glycopeptides for the study of self-assembling, adjuvant-free MUC1 glycopeptide vaccines. Q11 peptide holds great potential for research in the field of cancer immunology .

HY-W1049091E

mPEG-Alkyne (MW 3400)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 3400) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091B

mPEG-Alkyne (MW 10000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 10000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091D

mPEG-Alkyne (MW 40000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 40000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091A

mPEG-Alkyne (MW 5000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 5000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049105

mPEG-Alkyne (MW 2000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 2000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091

mPEG-Alkyne (MW 1000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 1000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091C

mPEG-Alkyne (MW 20000)	Biochemical Assay Reagents	Others
mPEG-Alkyne (MW 20000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-174809A

6-Arm-PEG-Mal (MW 600)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 600) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809E

6-Arm-PEG-Mal (MW 5000)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 5000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809H

6-Arm-PEG-Mal (MW 10000)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 10000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809

6-Arm-PEG-Mal (MW 400)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809C

6-Arm-PEG-Mal (MW 2000)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 2000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809D

6-Arm-PEG-Mal (MW 3400)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 3400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809B

6-Arm-PEG-Mal (MW 1000)	Biochemical Assay Reagents	Others
6-Arm-PEG-Mal (MW 1000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-P1778

HPV16 E7 (86-93)	HPV	Infection
HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas .

HY-P1778A

HPV16 E7 (86-93) (TFA)	HPV	Infection
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas .

HY-W1049092

mPEG-N3 (MW 2000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 2000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 2000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092D

mPEG-N3 (MW 40000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 40000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 40000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092H

mPEG-N3 (MW 3400)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 3400) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 3400) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092C

mPEG-N3 (MW 20000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 20000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 20000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092A

mPEG-N3 (MW 5000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 5000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 5000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092E

mPEG-N3 (MW 1000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 1000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 1000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092B

mPEG-N3 (MW 10000)	Biochemical Assay Reagents	Others
mPEG-N3 (MW 10000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 10000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-P1684

Peptide P60 FOXP3 inhibitor P60	NF-κB Nuclear Factor of activated T Cells (NFAT)	Infection Inflammation/Immunology Cancer
Peptide P60 is a FOXP3 inhibitor. Peptide P60 can enter cells, inhibit the nuclear translocation of FOXP3, and diminish its ability to suppress the transcription factors NF-κB and NFAT. Peptide P60 can inhibit the immunosuppressive activity of regulatory T cells (Treg) derived from mice and humans, and enhance the stimulation of effector T cells in vitro. Peptide P60 can induce a lymphoproliferative autoimmune syndrome with pathological manifestations resembling those reported in scurfy mice lacking functional Foxp3. Peptide P60 can enhance the immunogenicity of cancer and viral vaccines.

HY-W591618D

4-Arm-PEG-Maleimide (MW 3400) 4-Arm-PEG-Mal (MW 3400)	Biochemical Assay Reagents	Others
4-Arm-PEG-Maleimide (MW 3400) (4-Arm-PEG-Mal (MW 3400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618B

4-Arm-PEG-Maleimide (MW 600) 4-Arm-PEG-Mal (MW 600)	Biochemical Assay Reagents	Others
4-Arm-PEG-Maleimide (MW 600) (4-Arm-PEG-Mal (MW 600)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591465

4-Arm-PEG-Maleimide (MW 2000) 4-Arm-PEG-Mal (MW 2000)	Biochemical Assay Reagents	Others
4-Arm-PEG-Maleimide (MW 2000) (4-Arm-PEG-Mal (MW 2000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618A

4-Arm-PEG-Maleimide (MW 400) 4-Arm-PEG-Mal (MW 400)	Biochemical Assay Reagents	Others
4-Arm-PEG-Maleimide (MW 400) (4-Arm-PEG-Mal (MW 400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618C

4-Arm-PEG-Maleimide (MW 1000) 4-Arm-PEG-Mal (MW 1000)	Biochemical Assay Reagents	Others
4-Arm-PEG-Maleimide (MW 1000) (4-Arm-PEG-Mal (MW 1000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-P10295

p53 (232-240)	MDM-2/p53	Cancer
p53 (232-240) is a peptide segment of the 232-240 amino acid sequence of the human tumor suppressor protein p53. p53 (232-240) enhances its binding affinity to the Major histocompatibility complex (MHC), thereby enhancing the immunogenicity of this peptide to enhance the immune system's response to tumor antigens. p53 (232-240) can be used in the development of cancer vaccines and in the study of tumor cell recognition and clearance by the immune system .

HY-W451406B

NH2-PEG-NH2 (MW 1000)	Biochemical Assay Reagents	Others
NH2-PEG-NH2 (MW 1000) is a polyethylene glycol derivative containing two primary amine groups. The amino group can react quickly with activated carboxylic acid or carboxyl groups such as NHS esters to form stable amide bonds. The PEGylation of NH2-PEG-NH2 can increase solubility and stability, and reduce the immunogenicity of peptides and proteins, so it is mostly used to modify proteins, peptides and other substances.

HY-W451406C

NH2-PEG-NH2 (MW 2000)	Biochemical Assay Reagents	Others
NH2-PEG-NH2 (MW 2000) is a polyethylene glycol derivative containing two primary amine groups. The amino group can react quickly with activated carboxylic acid or carboxyl groups such as NHS esters to form stable amide bonds. The PEGylation of NH2-PEG-NH2 can increase solubility and stability, and reduce the immunogenicity of peptides and proteins, so it is mostly used to modify proteins, peptides and other substances.

HY-W451406D

NH2-PEG-NH2 (MW 10000)	Biochemical Assay Reagents	Others
NH2-PEG-NH2 (MW 10000) is a polyethylene glycol derivative containing two primary amine groups. The amino group can react quickly with activated carboxylic acid or carboxyl groups such as NHS esters to form stable amide bonds. The PEGylation of NH2-PEG-NH2 can increase solubility and stability, and reduce the immunogenicity of peptides and proteins, so it is mostly used to modify proteins, peptides and other substances.

HY-W451406A

NH2-PEG-NH2 (MW 5000)	Biochemical Assay Reagents	Others
NH2-PEG-NH2 (MW:5000) is a polyethylene glycol derivative containing two primary amine groups. The amino group can react quickly with activated carboxylic acid or carboxyl groups such as NHS esters to form stable amide bonds. The PEGylation of NH2-PEG-NH2 can increase solubility and stability, and reduce the immunogenicity of peptides and proteins, so it is mostly used to modify proteins, peptides and other substances.

HY-P10371

PKHB1 txCD47	Reactive Oxygen Species (ROS) Thrombopoietin Receptor	Inflammation/Immunology Cancer
PKHB1 is a thrombospondin-1 peptide mimic with antitumor effects. PKHB1 induces mitochondrial alterations, ROS production, intracellular Ca ²⁺ accumulation, as well calcium-dependent cell death in breast cancer cells. PKHB1 induces immune system activation through immunogenic cell death induction in breast cancer cells .

HY-P5295

Cy3-Ova (323-339)	Fluorescent Dye	Others
Cy3-Ova (323-339) is an Cy3 labled OVA Peptide (323-339) (HY-P0286). Cy3 is a fluorescent dye belonging to the Cyanine family and is a fluorescent light product of Cy5. Cyanine is commonly used in fluorescence microscopy, cell imaging, and molecular biology experiments. OVA Peptide (323-339) represents the T and B cell epitopes of ovalbumin (OVA). OVA Peptide (323-339) has limited immunogenic efficacy in activating OVA-sensitized and attacked mouse spleen cells .

HY-P10593

Influenza A NP (383-391) (HLA-B27)	Transmembrane Glycoprotein Influenza Virus	Cancer
Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. Influenza A NP (383-391) (HLA-B27) is a broadly immunogenic CD4+ T helper cell epitope that enhances CD8+ cytotoxic T lymphocyte (CTL) responses. Influenza A NP (383-391) (HLA-B27) can be used in breast cancer research .

HY-174961C

Fmoc-PEG-Maleimide (MW 5000) Fmoc-NH-PEG-Mal (MW 5000)	Biochemical Assay Reagents	Others
Fmoc-PEG-Maleimide (MW 5000) (Fmoc-NH-PEG-Mal (MW 5000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174960D

6-Arm-PEG-FA (MW 3400) 6-Arm-PEG-Folate (MW 3400)	Biochemical Assay Reagents	Others
6-Arm-PEG-FA (MW 3400) (6-Arm-PEG-Folate (MW 3400)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

Cat. No.	Product Name

HY-L033

Peptidomimetic Library

372 compounds

Peptidomimetics are compounds whose essential elements (pharmacophore) mimic a natural peptide or protein in 3D space and which retain the ability to interact with the biological target and produce the same biological effect. Peptidomimetics are designed to circumvent some of the problems associated with a natural peptide: e.g. stability against proteolysis (duration of activity) and poor bioavailability. Certain other properties, such as receptor selectivity or potency, often can be substantially improved. The design and synthesis of peptidomimetics are most important because of the dominant position peptide and protein-protein interactions play in molecular recognition and signaling, especially in living systems. Hence mimics have great potential in drug discovery.

MCE Peptidomimetic Library contains 372 compounds including peptoid, α-helix mimetics, β-turn/sheets mimetics, etc. This library is an indispensable tool of structure-activity relationships in drug discovery.

Cat. No.	Product Name	Type

HY-P2853A

Hemocyanin-SMCC	Native Proteins
Hemocyanin-SMCC is a hemocyanin that can be used as a carrier protein to couple low molecular weight molecules such as peptides, nucleic acids, drugs or toxins to make them highly immunogenic.

HY-174359C

Alkyne-PEG-NH2 (MW 5000)	Drug Delivery
Alkyne-PEG-NH2 (MW 5000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359D

Alkyne-PEG-NH2 (MW 10000)	Drug Delivery
Alkyne-PEG-NH2 (MW 10000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359

Alkyne-PEG-NH2 (MW 1000)	Drug Delivery
Alkyne-PEG-NH2 (MW 1000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359B

Alkyne-PEG-NH2 (MW 3400)	Drug Delivery
Alkyne-PEG-NH2 (MW 3400) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359E

Alkyne-PEG-NH2 (MW 20000)	Drug Delivery
Alkyne-PEG-NH2 (MW 20000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359H

Alkyne-PEG-NH2 (MW 40000)	Drug Delivery
Alkyne-PEG-NH2 (MW 40000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-174359A

Alkyne-PEG-NH2 (MW 2000)	Drug Delivery
Alkyne-PEG-NH2 (MW 2000) is an alkyne-functionalized bifunctional PEG derivative that can be used to modify proteins, peptides, and other materials. The alkyne group reacts with azides in aqueous solution in a copper-catalyzed manner. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins .

HY-W1049091E

mPEG-Alkyne (MW 3400)	Drug Delivery
mPEG-Alkyne (MW 3400) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091B

mPEG-Alkyne (MW 10000)	Drug Delivery
mPEG-Alkyne (MW 10000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091D

mPEG-Alkyne (MW 40000)	Drug Delivery
mPEG-Alkyne (MW 40000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091A

mPEG-Alkyne (MW 5000)	Drug Delivery
mPEG-Alkyne (MW 5000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049105

mPEG-Alkyne (MW 2000)	Drug Delivery
mPEG-Alkyne (MW 2000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091

mPEG-Alkyne (MW 1000)	Drug Delivery
mPEG-Alkyne (MW 1000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091C

mPEG-Alkyne (MW 20000)	Drug Delivery
mPEG-Alkyne (MW 20000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-174809A

6-Arm-PEG-Mal (MW 600)	Drug Delivery
6-Arm-PEG-Mal (MW 600) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809E

6-Arm-PEG-Mal (MW 5000)	Drug Delivery
6-Arm-PEG-Mal (MW 5000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809H

6-Arm-PEG-Mal (MW 10000)	Drug Delivery
6-Arm-PEG-Mal (MW 10000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809

6-Arm-PEG-Mal (MW 400)	Drug Delivery
6-Arm-PEG-Mal (MW 400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809C

6-Arm-PEG-Mal (MW 2000)	Drug Delivery
6-Arm-PEG-Mal (MW 2000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809D

6-Arm-PEG-Mal (MW 3400)	Drug Delivery
6-Arm-PEG-Mal (MW 3400) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174809B

6-Arm-PEG-Mal (MW 1000)	Drug Delivery
6-Arm-PEG-Mal (MW 1000) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W1049092

mPEG-N3 (MW 2000)

Drug Delivery

mPEG-N3 (MW 2000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 2000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092D

mPEG-N3 (MW 40000)

Drug Delivery

mPEG-N3 (MW 40000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 40000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092H

mPEG-N3 (MW 3400)

Drug Delivery

mPEG-N3 (MW 3400) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 3400) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092C

mPEG-N3 (MW 20000)

Drug Delivery

mPEG-N3 (MW 20000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 20000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092A

mPEG-N3 (MW 5000)

Drug Delivery

mPEG-N3 (MW 5000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 5000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092E

mPEG-N3 (MW 1000)

Drug Delivery

mPEG-N3 (MW 1000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 1000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092B

mPEG-N3 (MW 10000)

Drug Delivery

mPEG-N3 (MW 10000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 10000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W591618D

4-Arm-PEG-Maleimide (MW 3400) 4-Arm-PEG-Mal (MW 3400)	Drug Delivery
4-Arm-PEG-Maleimide (MW 3400) (4-Arm-PEG-Mal (MW 3400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618B

4-Arm-PEG-Maleimide (MW 600) 4-Arm-PEG-Mal (MW 600)	Drug Delivery
4-Arm-PEG-Maleimide (MW 600) (4-Arm-PEG-Mal (MW 600)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591465

4-Arm-PEG-Maleimide (MW 2000) 4-Arm-PEG-Mal (MW 2000)	Drug Delivery
4-Arm-PEG-Maleimide (MW 2000) (4-Arm-PEG-Mal (MW 2000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618A

4-Arm-PEG-Maleimide (MW 400) 4-Arm-PEG-Mal (MW 400)	Drug Delivery
4-Arm-PEG-Maleimide (MW 400) (4-Arm-PEG-Mal (MW 400)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-W591618C

4-Arm-PEG-Maleimide (MW 1000) 4-Arm-PEG-Mal (MW 1000)	Drug Delivery
4-Arm-PEG-Maleimide (MW 1000) (4-Arm-PEG-Mal (MW 1000)) is a PEG derivative modified with Maleimide (HY-W007324), which forms a stable thioether bond with sulfhydryl (-SH). PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174961C

Fmoc-PEG-Maleimide (MW 5000)

Fmoc-NH-PEG-Mal (MW 5000)

Drug Delivery

Fmoc-PEG-Maleimide (MW 5000) (Fmoc-NH-PEG-Mal (MW 5000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174960D

6-Arm-PEG-FA (MW 3400)

6-Arm-PEG-Folate (MW 3400)

Drug Delivery

6-Arm-PEG-FA (MW 3400) (6-Arm-PEG-Folate (MW 3400)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174960E

6-Arm-PEG-FA (MW 5000)

6-Arm-PEG-Folate (MW 5000)

Drug Delivery

6-Arm-PEG-FA (MW 5000) (6-Arm-PEG-Folate (MW 5000)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174960B

6-Arm-PEG-FA (MW 1000)

6-Arm-PEG-Folate (MW 1000)

Drug Delivery

6-Arm-PEG-FA (MW 1000) (6-Arm-PEG-Folate (MW 1000)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174961B

Fmoc-PEG-Maleimide (MW 3400)

Fmoc-NH-PEG-Mal (MW 3400)

Drug Delivery

Fmoc-PEG-Maleimide (MW 3400) (Fmoc-NH-PEG-Mal (MW 3400)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174961

Fmoc-PEG-Maleimide (MW 1000)

Fmoc-NH-PEG-Mal (MW 1000)

Drug Delivery

Fmoc-PEG-Maleimide (MW 1000) (Fmoc-NH-PEG-Mal (MW 1000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174960A

6-Arm-PEG-FA (MW 600)

6-Arm-PEG-Folate (MW 600)

Drug Delivery

6-Arm-PEG-FA (MW 600) (6-Arm-PEG-Folate (MW 600)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174960C

6-Arm-PEG-FA (MW 2000)

6-Arm-PEG-Folate (MW 2000)

Drug Delivery

6-Arm-PEG-FA (MW 2000) (6-Arm-PEG-Folate (MW 2000)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174961A

Fmoc-PEG-Maleimide (MW 2000)

Fmoc-NH-PEG-Mal (MW 2000)

Drug Delivery

Fmoc-PEG-Maleimide (MW 2000) (Fmoc-NH-PEG-Mal (MW 2000)) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .

HY-174960

6-Arm-PEG-FA (MW 400)

6-Arm-PEG-Folate (MW 400)

Drug Delivery

6-Arm-PEG-FA (MW 400) (6-Arm-PEG-Folate (MW 400)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

HY-174960H

6-Arm-PEG-FA (MW 10000)

6-Arm-PEG-Folate (MW 10000)

Drug Delivery

6-Arm-PEG-FA (MW 10000) (6-Arm-PEG-Folate (MW 10000)) is a PEG derivative modified with Folic acid (HY-16637). Polyethylene glycol can increase solubility and stability and reduce the immunogenicity of peptides and proteins. It can also inhibit the nonspecific binding of charged molecules to modified surfaces. Folic acid (-FA) has a high affinity for folate receptors and can be used for cell membrane receptors for targeted drug delivery .

Cat. No.	Product Name	Target	Research Area

HY-P6355

CAP1-6D	Peptides	Inflammation/Immunology
CAP1-6D is an agonist peptide for cytotoxic T cell (CTL), that enhances the immunogenicity of the CAPI peptide, and stimulates T cell responses .

HY-P3486

GADGVGKSAL	Peptides	Inflammation/Immunology Cancer
GADGVGKSAL is a mutant KRAS G12D 10mer peptide. GADGVGKSAL can be used as an immunogenic neoantigen for cancer immunotherapy research .

HY-P3488

GADGVGKSA	Peptides	Inflammation/Immunology Cancer
GADGVGKSA is a mutant KRAS G12D 9mer peptide. GADGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research .

HY-P3485

GAGGVGKSAL	Peptides	Cancer
GAGGVGKSAL is a wild-type KRAS G12D 10mer peptide. GAGGVGKSAL can be used as an immunogenic neoantigen for cancer immunotherapy research .

HY-P3487

GAGGVGKSA	Peptides	Inflammation/Immunology Cancer
GAGGVGKSA is a wild type KRAS G12D 9mer peptide. GAGGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research .

HY-P3719

MOG(35-55) amide, mouse, rat 1 Publications Verification	CCR	Inflammation/Immunology
MOG peptide (35-55) is a fragment 35-55 of myelin oligodendrocyte glycoprotein (MOG) immunogenic peptide. MOG peptide (35-55) is specific to expanded CD4 ⁺ T cells, and induces experimental autoimmune encephalomyelitis (EAE) in animal model .

HY-P10020

Alrefimotide hTERT (660–689)	Peptides	Cancer
Alrefimotide is a hTERT-derived **immunogenic peptide. Alrefimotide has a sequence of ALFSVLNYERARRPGLLGASVLGLDDIHRA. Alrefimotide can be used in cancer immunotherapy** research .

HY-P1610

Asudemotide	PD-1/PD-L1	Cancer
Asudemotide (S-588410) is a peptide of human DEP domain-containing protein 1A. Asudemotide is an immunostimulant. Asudemotide has a sequence of H-Glu-Tyr-Tyr-Glu-Leu-Phe-Val-Asn-Ile-OH. Asudemotide induces a tumor immune response in esophageal cancer. .

HY-P5273

FLAG-Cys	Peptides	Inflammation/Immunology
FLAG-Cys is a Flag peptide with a Cys residue. FLAG-Cys has immunogenicity .

HY-P1870

OVA sequence (323-336)	Peptides	Inflammation/Immunology
OVA sequence (323-336) is a cognate helper T-lymphocyte peptide that is employed to enhance CTL epitope immunogenicity.

HY-P10701

Q11 peptide	Biochemical Assay Reagents	Inflammation/Immunology Cancer
Q11 peptide is a β-sheet-forming peptide that plays an important role in self-assembly and targeted applications. As a scaffold peptide, Q11 peptide can display immunogenic epitopes and is widely used in peptide-based immune vaccine research. Additionally, Q11 peptide can be conjugated with MUC1 glycopeptides for the study of self-assembling, adjuvant-free MUC1 glycopeptide vaccines. Q11 peptide holds great potential for research in the field of cancer immunology .

HY-P1778

HPV16 E7 (86-93)	HPV	Infection
HPV16 E7 (86-93) is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) is immunogenic in cervical carcinomas .

HY-P1778A

HPV16 E7 (86-93) (TFA)	HPV	Infection
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide. HPV16 E7 (86-93) TFA is immunogenic in cervical carcinomas .

HY-P1684

Peptide P60 FOXP3 inhibitor P60	NF-κB Nuclear Factor of activated T Cells (NFAT)	Infection Inflammation/Immunology Cancer
Peptide P60 is a FOXP3 inhibitor. Peptide P60 can enter cells, inhibit the nuclear translocation of FOXP3, and diminish its ability to suppress the transcription factors NF-κB and NFAT. Peptide P60 can inhibit the immunosuppressive activity of regulatory T cells (Treg) derived from mice and humans, and enhance the stimulation of effector T cells in vitro. Peptide P60 can induce a lymphoproliferative autoimmune syndrome with pathological manifestations resembling those reported in scurfy mice lacking functional Foxp3. Peptide P60 can enhance the immunogenicity of cancer and viral vaccines.

HY-P10295

p53 (232-240)	MDM-2/p53	Cancer
p53 (232-240) is a peptide segment of the 232-240 amino acid sequence of the human tumor suppressor protein p53. p53 (232-240) enhances its binding affinity to the Major histocompatibility complex (MHC), thereby enhancing the immunogenicity of this peptide to enhance the immune system's response to tumor antigens. p53 (232-240) can be used in the development of cancer vaccines and in the study of tumor cell recognition and clearance by the immune system .

HY-P10371

PKHB1 txCD47	Reactive Oxygen Species (ROS) Thrombopoietin Receptor	Inflammation/Immunology Cancer
PKHB1 is a thrombospondin-1 peptide mimic with antitumor effects. PKHB1 induces mitochondrial alterations, ROS production, intracellular Ca ²⁺ accumulation, as well calcium-dependent cell death in breast cancer cells. PKHB1 induces immune system activation through immunogenic cell death induction in breast cancer cells .

HY-P5295

Cy3-Ova (323-339)	Fluorescent Dye	Others
Cy3-Ova (323-339) is an Cy3 labled OVA Peptide (323-339) (HY-P0286). Cy3 is a fluorescent dye belonging to the Cyanine family and is a fluorescent light product of Cy5. Cyanine is commonly used in fluorescence microscopy, cell imaging, and molecular biology experiments. OVA Peptide (323-339) represents the T and B cell epitopes of ovalbumin (OVA). OVA Peptide (323-339) has limited immunogenic efficacy in activating OVA-sensitized and attacked mouse spleen cells .

HY-P5471

Melan-A/MART-1 analog [Leu27]-Melan-A, MART-1 (26-35)	Peptides	Others
Melan-A/MART-1 analog ([Leu27]-Melan-A, MART-1 (26-35)) is a biological active peptide. (This Melan-A (26-35) analog, Leu substituted for Ala at position 27, shows better HLA-A0201 binding properties as well as better immunogenicity* and antigenicity than the natural Melan-A (26-35).Pyroglutamyl (pGlu) peptides may spontaneously form when either Glutamine (Q) or Glutamic acid (E) is located at the sequence N-terminus. The conversion of Q or E to pGlu is a natural occurrence and in general it is believed that the hydrophobic γ-lactam ring of pGlu may play a role in peptide stability against gastrointestinal proteases. Pyroglutamyl peptides are therefore considered a normal subset of such peptides and are included as part of the peptide purity during HPLC analysis.)

HY-P10491

MAGE A4 (230-239)	Peptides	Cancer
MAGE A4 (230-239) is a peptide sequence derived from the MAGE-A4 protein. MAGE A4 (230-239) is an immunogenic epitope that can activate T cells and trigger the killing of tumor cells expressing MAGE-A4. MAGE A4 (230-239) is used in the development of next-generation T cell-based immunotherapies .

HY-P10593

Influenza A NP (383-391) (HLA-B27)	Transmembrane Glycoprotein Influenza Virus	Cancer
Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. Influenza A NP (383-391) (HLA-B27) is a broadly immunogenic CD4+ T helper cell epitope that enhances CD8+ cytotoxic T lymphocyte (CTL) responses. Influenza A NP (383-391) (HLA-B27) can be used in breast cancer research .

HY-P2459

MOG (35-55), human	MHC	Neurological Disease
MOG (35-55), human is a component of CNS myelin. MOG (35-55), human is different from mMOG (35-55) by a proline for serine substitution at position 42. MOG (35-55), human is also immunogenic via bind to H-2b class II MHC and recognized by T cells, but not encephalitogenic, and is only partially cross-reactive with mMOG35–55. MOG (35-55), human induces minimal clinical signs of EAE relative to the rodent peptide .

Cat. No.	Product Name		Classification

HY-W1049092

mPEG-N3 (MW 2000)		Azide
mPEG-N3 (MW 2000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 2000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049091E

mPEG-Alkyne (MW 3400)		Alkynes
mPEG-Alkyne (MW 3400) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091B

mPEG-Alkyne (MW 10000)		Alkynes
mPEG-Alkyne (MW 10000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091D

mPEG-Alkyne (MW 40000)		Alkynes
mPEG-Alkyne (MW 40000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091A

mPEG-Alkyne (MW 5000)		Alkynes
mPEG-Alkyne (MW 5000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049105

mPEG-Alkyne (MW 2000)		Alkynes
mPEG-Alkyne (MW 2000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091

mPEG-Alkyne (MW 1000)		Alkynes
mPEG-Alkyne (MW 1000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049091C

mPEG-Alkyne (MW 20000)		Alkynes
mPEG-Alkyne (MW 20000) is a PEG derivative. The alkynyl group can react with azide in aqueous solution under the catalysis of monovalent copper. Polyethylene glycol derivatives can increase the solubility and stability of drugs, reduce the immunogenicity of peptides, and have good biocompatibility .

HY-W1049092D

mPEG-N3 (MW 40000)		Azide
mPEG-N3 (MW 40000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 40000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092H

mPEG-N3 (MW 3400)		Azide
mPEG-N3 (MW 3400) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 3400) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092C

mPEG-N3 (MW 20000)		Azide
mPEG-N3 (MW 20000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 20000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092A

mPEG-N3 (MW 5000)		Azide
mPEG-N3 (MW 5000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 5000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092E

mPEG-N3 (MW 1000)		Azide
mPEG-N3 (MW 1000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 1000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

HY-W1049092B

mPEG-N3 (MW 10000)		Azide
mPEG-N3 (MW 10000) can be used to modify proteins, peptides, and other materials. The azide group can react with alkynes in aqueous solution catalyzed by copper. It can also be easily reduced to an amine group. PEGylation can increase solubility and stability and reduce the immunogenicity of peptides and proteins. mPEG-N3 (MW 10000) can also inhibit the nonspecific binding of charged molecules to the modified surface .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: